Merck & Co is on the brink of plugging a gap in the coronavirus treatment armamentarium after its oral drug molnupiravir cut deaths and hospitalisations in mild or moderate COVID-19 in a phase 3 ...

A drug against fungal infections in cancer patients can last twice as long in people with obesity, and may make chemotherapy ...

The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health ...

Deadly fungi including Candida auris have been spreading. Gilead and Merck are two pharma stocks worth owning amidst fungal ...

Belen Garijo took charge of German drug-to-semiconductor group Merck KGaA with the tailwind of the Covid pandemic, propelling the stock to an all-time high in 2021. Since then, the shares have ...

Merck KGaA said it’s seeing the beginning of a post-Covid pandemic rebound in life sciences as it reaffirmed the group’s sales and profit guidance for the full year. The German science and ...

Merck KGaA is a healthcare/pharma company that I have been covering and investing in for about 2 years at this point. Q2 2024 ...

The drug is also approved in Singapore. Xocova belongs to the same class of drugs as Pfizer’s (PFE) Paxlovid and Merck’s (MRK ...

A key panel of US health advisers voted in favor of lowering the age recommendation for vaccines made by Pfizer Inc. and Merck & Co. that ... decline in sales of its Covid-19 vaccine and treatment.

We recently compiled a list of the 8 Best Stocks to Buy for High Returns in 2024. In this article, we are going to take a ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE ... come down significantly ever since the outburst after COVID-19, hinting that there are a lot of positives to ...